Liver Cancer News and Research

RSS
Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.
Altered nitrogen metabolism may contribute to emergence of new cancer mutations

Altered nitrogen metabolism may contribute to emergence of new cancer mutations

Combination of arsenic and existing leukemia drug may combat cancer

Combination of arsenic and existing leukemia drug may combat cancer

Scientists identify two potential new drug targets for treatment of HIV

Scientists identify two potential new drug targets for treatment of HIV

Scientists develop novel peptide drug that could potentially stop development of liver cancer

Scientists develop novel peptide drug that could potentially stop development of liver cancer

Mushrooms from the Far East area could be used to design novel anti-cancer drugs

Mushrooms from the Far East area could be used to design novel anti-cancer drugs

Bayshore Medical Center now offers Y-90 radioembolization to treat liver tumors without surgery

Bayshore Medical Center now offers Y-90 radioembolization to treat liver tumors without surgery

Genetic factors may play a role in progression of liver injury in Caucasians with hepatitis B infection

Genetic factors may play a role in progression of liver injury in Caucasians with hepatitis B infection

Diet-induced obesity synchronizes opposing liver fat metabolic processes in mice

Diet-induced obesity synchronizes opposing liver fat metabolic processes in mice

Multi-center study results demonstrate best-in-class performance of Bladder EpiCheck urine test

Multi-center study results demonstrate best-in-class performance of Bladder EpiCheck urine test

Analysis reveals disparities in cancer death rates among minority groups

Analysis reveals disparities in cancer death rates among minority groups

Alcohol-related cirrhosis mortality on the rise among young adults

Alcohol-related cirrhosis mortality on the rise among young adults

Study calls for new gold standard in research to treat non-alcoholic steatohepatitis

Study calls for new gold standard in research to treat non-alcoholic steatohepatitis

Can-Fite BioPharma receives Australian and Chinese patents for new drug to treat erectile dysfunction

Can-Fite BioPharma receives Australian and Chinese patents for new drug to treat erectile dysfunction

Olfactory receptors perform a range of unknown functions outside the nose, reveals study

Olfactory receptors perform a range of unknown functions outside the nose, reveals study

Study: Hepatitis C vaccine could drastically reduce transmission among injecting drug users

Study: Hepatitis C vaccine could drastically reduce transmission among injecting drug users

American Cancer Society outlines vision for cancer control in the decades ahead

American Cancer Society outlines vision for cancer control in the decades ahead

Researchers focus on mechanisms involved in development of non-alcoholic fatty liver disease

Researchers focus on mechanisms involved in development of non-alcoholic fatty liver disease

U.S. researchers recommend development of anti-cancer drugs based on mechanism of Namodenoson

U.S. researchers recommend development of anti-cancer drugs based on mechanism of Namodenoson

Clinical trial targets metastatic colorectal cancer with new combination therapy

Clinical trial targets metastatic colorectal cancer with new combination therapy

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson